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S U M M A R Y
Background: Acute invasive fungal rhinosinusitis (AIFRS) is a rare disease with high morbidity and
mortality rates. The objective of this study was to correlate the initial clinical features of AIFRS to the
prognosis after surgery.
Methods: Thirty-two patients with AIFRS were evaluated retrospectively. The correlation of underlying
disease, fungus isolated, and extent of the disease to the clinical outcome of AIFRS was also evaluated.
Results: The most common underlying disease was hematological malignancy and aplasia (n = 20).
Aspergillus (n = 13) and Mucoraceae (n = 11) were the main fungi found in AIFRS. Mucosal biopsy
conﬁrmed fungal invasion to the nasal mucosa in all cases. Computed tomography and endoscopic
ﬁndings showed a predominance of unilateral disease, with various stages of nasal involvement. All
patients underwent surgical debridement and systemic antifungal therapy immediately after diagnosis.
Sixteen patients died (50%) due to AIFRS. A poor prognosis was related to the extensiveness of AIFRS and
to the underlying disease (patients with aplastic anemia and diabetes had the worst outcomes), but not
to the fungus isolated.
Conclusions: Early medical and surgical treatment is essential to improve the prognosis of AIFRS
patients. A poorer prognosis was associated with underlying disease and extensiveness of AIFRS, but not
to the fungus isolated.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Controversy remains regarding the classiﬁcation of fungal
rhinosinusitis, however the most accepted categorization of this
entity was proposed by deShazo et al.,1 who differentiated fungal
rhinosinusitis into non-invasive and invasive forms based on
histopathological ﬁndings. Invasive fungal rhinosinusitis is sub-
categorized into three groups: granulomatous invasive, chronic
invasive, and acute invasive fungal rhinosinusitis (AIFRS). Granu-
lomatous invasive rhinosinusitis occurs in immunocompetent
patients, and there is a geographic predominance of this disease in
Asia. Chronic invasive fungal rhinosinusitis usually occurs in
mildly immunocompromised patients, mainly in diabetic individ-
uals; nasal symptoms are occasional, but orbital and neurological
symptoms, especially those related to orbital apex syndrome, are
pathognomonic of this entity.AIFRS is a special entity because it
occurs almost exclusively in immunocompromised patients,
particularly in the presence of a cellular immunodeﬁciency. There
is rapid spread of the fungi from the nasal mucosa and sinus to the
orbit and brain. Necrosis and angioinvasion are characteristic of* Corresponding author. Tel.: +55 16 3602 2862; fax: +55 16 3602 2860.
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revealing fungal invasion associated with necrosis in the nasal
mucosa and underlying bone. The mortality rate in this setting is
reported to be high, ranging from 50% to 80%.2–4
The initial symptoms may not be characteristic, and include
fever, nasal discharge, obstruction, and nasal crusting. More
extensive disease may present with visual complaints, neurological
deﬁcits, or palatal erosion. In immunocompromised patients with
these symptoms, especially if they are unilateral, nasal endoscopy is
essential, and pale or ischemic mucosae are characteristic of this
entity.
New approaches to hematological diseases, HIV/AIDS, and
diabetes mellitus have improved survival rates, however some
of these medical advances have also resulted in an increase in
the population at risk of developing AIFRS.5 Therefore, recognition
of the underlying disease that caused the immunodeﬁciency
and its correction, if possible, are pivotal to improve the survival
rate in patients with AIFRS. Hence, the goals of treatment in AIFRS
are the reestablishment of the immune response associated with
systemic antifungal therapy and surgical debridement of necrotic
sites.2,6
In this study we reviewed a series of AIFRS patients treated at a
tertiary hospital and evaluated the prognostic factors. Results
obtained were compared to data reported in the literature.ses. Published by Elsevier Ltd. All rights reserved.
Figure 2. Leukemia patient with acute invasive fungal rhinosinusitis localized to the
middle turbinate. Note the severe mucosal edema in unilateral middle turbinate.
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This was a retrospective study of 32 immunocompromised
patients with AIFRS, who were evaluated at the Division of
Otorhinolaryngology, School of Medicine of Ribeira˜o Preto,
University of Sa˜o Paulo. When the disease was suspected a
diagnostic biopsy was performed, which was sent immediately to
the pathology department. Only patients who had their diagnosis
conﬁrmed by histopathology were included in this series. The
study was approved by the ethics committee of the institution
(process number 4889/2009).
The following clinical parameters were evaluated: the under-
lying cause of the immunodeﬁciency, the initial clinical presenta-
tion, endoscopic ﬁndings (evaluating the extent of the diseased
mucosa), and computed tomography (CT) scan ﬁndings according
to Lund and MacKay.7 During the ﬁrst outpatient evaluation, a
biopsy of the suspected area was obtained with the aid of a nasal
endoscopy, and was submitted to histopathology to conﬁrm the
fungal invasion and also to establish the classiﬁcation of the
fungus.
The surgical and clinical approaches in the treatment of AIFRS
were retrieved from the medical records, as well as the clinical
follow-up of each patient.
The analysis of variance (ANOVA) test was used to correlate the
type of fungus isolated, the endoscopic ﬁndings at ﬁrst outpatient
evaluation, and the underlying disease, to the clinical outcome.
Also, the extent of the disease on CT scan was compared between
patients with a good outcome and those with a poor outcome,
using the unpaired Student’s t-test with the Welch correction.
Differences were considered to be statistically signiﬁcant when
p < 0.05.
3. Results
Of the 32 study patients, 14 were male and 18 were female;
patients ranged in age from 8 to 70 years. The underlying causes of
the immunodeﬁciency were: hematological disease (aplastic
anemia (n = 5) and leukemia (n = 15)), diabetes (n = 6), AIDS
(n = 5), and renal failure (n = 1).
The most frequent symptoms reported by the patients were
fever, nasal obstruction, headache, and purulent rhinorrhea with
nasal crusting. In 18 patients, complaints were unilateral, whereas
in 14 the symptoms were bilateral. Extra-sinonasal extension wasFigure 1. Palate necrosis in a bone marrow transplant child with acute invasive
fungal rhinosinusitis.observed in three patients, one with palatal ulcers (Figure 1), the
second with ulcers in the nasopharynx, and the third with brain
extension of the disease.
The most common endoscopic ﬁndings were pale or necrotic
mucosae, intense necrotic nasal crusting, and hyaline or thick
mucus secretion. The middle meatus and middle turbinates were
the sites most frequently involved (n = 26), followed by the inferior
turbinates (n = 11) and nasal septum (n = 8). During nasal
endoscopy, unilateral necrosis was found in 23 cases and bilateral
necrosis in six. The remaining three patients had no changes on
endoscopy.
CT scans revealed changes in bone density and sinus opacity in
all cases. There was a predominance of unilateral involvement (26
of 32 cases). The middle meatus was the most affected site (n = 26),
either isolated (n = 9) (Figure 2) or associated with maxillary and
ethmoidal opacity (n = 17). Two patients presented more diffuse
opacity, from frontal to sphenoid (Figure 3). Three patients had
orbital involvement (Figure 4) and one had intracranial extension.
The outpatient biopsies conﬁrmed the fungal invasion to the
nasal mucosa in all cases. The fungi isolated were: Aspergillus in 13
patients, Mucoraceae in 11, and Fusarium in two; the fungus
classiﬁcation could not be obtained in six cases (Table 1). There
was a signiﬁcant correlation of fungus classiﬁcation with
associated diseases (p < 0.01): for diabetic patients there was a
correlation with cultures positive for Mucoraceae (ﬁve out of six),
while for patients with leukemia there was a positive correlation
with Aspergillus (nine out of 15).
All patients underwent surgical debridement and systemic
antifungal therapy. The majority of the patients (n = 26, 81%)
underwent unilateral surgery. The standard surgical procedureFigure 3. Patient with unilateral acute invasive fungal rhinosinusitis, diffuse to all
sinuses on the left side. Note the change in density in the bony area, suggesting bone
erosion, and the important mucosal edema.
Figure 4. Patient with unilateral acute invasive fungal rhinosinusitis and proptosis.
The lamina papyracea bone is affected and the inferior orbital muscle is inﬁltrated.
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maxillary antrostomy and anterior ethmoidectomy for all surgical
cases. In addition to surgical treatment, all patients received
systemic antifungal therapy. Amphotericin B was the drug of
choice, employed as monotherapy in 21 patients and in association
with other antifungal drugs in six patients. In those cases whereTable 1
Underlying diseases, fungal identiﬁcation, extensiveness of disease, and follow-up of t
Patient Underlying disease Isolated fungus Ex
1 Aplastic anemia/hepatitis B Aspergillus ﬂavus Bil
2 Aplastic anemia/hepatitis B Mucoraceae Bil
ma
3 Aplastic anemia/Aspergillus pneumonia Mucoraceae Di
4 Aplastic anemia Aspergillus Le
5 Aplastic anemia Fusarium Le
na
6 Acute myeloid leukemia Inconclusive Le
7 Acute myeloid leukemia/Aspergillus pneumonia Aspergillus ﬂavus Bil
8 Acute myeloid leukemia Aspergillus ﬂavus Rig
9 Acute myeloid leukemia Mucoraceae Le
10 Acute myeloid leukemia Aspergillus Le
po
11 Acute myeloid leukemia Inconclusive Le
12 Acute myeloid leukemia/histoplasmosis Mucoraceae Rig
13 Chronic lymphoid leukemia Aspergillus Le
14 Acute myeloid leukemia Aspergillus Bil
15 Acute myeloid leukemia Aspergillus ﬂavus Rig
16 Acute myeloid leukemia Aspergillus fumigatus Le
or
17 Acute myeloid leukemia Aspergillus fumigatus Bil
18 Acute lymphoid leukemia Aspergillus ﬂavus Le
na
19 Acute lymphoid leukemia Mucoraceae Le
or
20 Acute myeloid leukemia Fusarium Rig
21 Diabetes mellitus Mucoraceae Rig
22 Diabetes mellitus Mucoraceae Le
23 Diabetes mellitus Mucoraceae Rig
24 Diabetes mellitus Inconclusive Le
25 Diabetes mellitus Mucoraceae Bil
lat
26 Diabetes mellitus Mucoraceae Rig
27 AIDS Aspergillus ﬂavus Rig
28 AIDS Inconclusive Rig
29 AIDS Mucoraceae Rig
30 AIDS/non-Hodgkin lymphoma Inconclusive Le
31 AIDS Inconclusive Le
32 Chronic renal failure Aspergillus fumigatus LeAspergillus was promptly identiﬁed or when amphotericin could
not be used due to adverse effects, voriconazole and ﬂuconazole
were the drugs employed.
After surgery, patients were followed-up with periodic
endoscopic examinations during antifungal therapy, and further
CT scans or biopsies were requested depending on the endoscopic
ﬁndings. Five patients required revisional surgery. Sixteen patients
(50%) died within 30 days of the AIFRS diagnosis due to the extent
of fungal invasion, pneumonia, or sepsis. The remaining 16 (50%)
patients with AIFRS are long-term survivors.
The fungus identiﬁed in the specimens did not correlate with
the clinical outcome after surgery; 46% of patients with Aspergillus
and 60% with Mucoraceae died. In contrast, the clinical outcome
was associated with the underlying disease, and patients with a
poorer prognosis included those with aplastic anemia (all ﬁve
patients died) and diabetes mellitus (ﬁve out of six patients died);
those with an intermediate prognosis included patients with
hematological diseases (six out of 15 patients died). Patients with
AIDS/HIV or renal insufﬁciency presented a better prognosis (all six
patients are currently alive). Statistical analysis between these
three sub-groups through ANOVA was signiﬁcant (p < 0.005).
Moreover, the prognosis was related to the extent of the disease
observed during surgery: in patients with ischemia limited to the
turbinates or lateral wall, the mortality rate was 33%; when the
nasal septum was involved, the mortality rate increased to 67%,
and ultimately, when dissemination extended beyond the nasal
cavities, the mortality rate reached 100% in our series. The ANOVA
test was statistically signiﬁcant for this comparison (p < 0.05).he study patients
tent of the disease Follow-up
ateral inferior turbinates Died
ateral inferior and middle turbinates, ethmoid and
xillary accomplishment
Died
ffuse sinus accomplishment Died
ft middle turbinate and left side of nasal septum Died
ft middle and inferior turbinates, lateral nasal wall,
sal septum; intracranial extension
Died
ft middle turbinate and maxillary sinus 8 months
ateral middle turbinates 4 months
ht middle and inferior turbinates 3 months
ft middle turbinate 80 months
ft inferior and middle turbinates, anterior and
sterior ethmoid
7 months
ft middle and inferior turbinates 12 months
ht middle turbinate 3 months
ft middle turbinate 4 months
ateral middle turbinates, nasal septum 24 months
ht middle turbinate and maxillary sinus Died
ft middle and inferior turbinates, lateral nasal wall,
bital inﬁltration
Died
ateral middle turbinates and left middle meatus Died
ft inferior turbinate, right side of nasal septum,
sopharynx, oral lesions
Died
ft lateral nasal wall and nasal septum, hard palate,
bital inﬁltration
Died
ht middle and inferior turbinates, lateral nasal wall Died
ht maxillary sinus mucosal edema Died
ft middle turbinate 8 months
ht middle turbinate, ethmoid opacity, orbital inﬁltration Died
ft middle turbinates, frontal to sphenoid sinus accomplishment Died
ateral middle and inferior turbinates, bilateral nasal
eral wall, nasal septum
Died
ht middle and inferior turbinates, lateral nasal wall Died
ht middle meatus, nasal septum 13 months
ht middle and inferior turbinates, lateral nasal wall, nasal septum 4 months
ht middle meatus, ethmoid opacity 5 months
ft middle meatus, maxillary sinus and middle turbinates 7 months
ft sphenoid 4 months
ft middle meatus 3 months
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The main purpose of this study was to determine the clinical
features that are associated with the prognosis in patients with
AIFRS.
The incidence of AIFRS reported in the literature in immuno-
compromised patients is around 2%, and patients with hemato-
logical diseases are the most susceptible group.3 In the present
study, neutropenia, either due to aplastic anemia or secondary to
chemotherapy for hematological malignancies, was the main cause
of AIFRS (62%), a ﬁnding similar to that reported in other studies in
the literature.8,9
Aspergillus and Mucoraceae account for the majority of cases of
AIFRS.3,9 Both fungi are saprophytes, found worldwide in dust and
soil.5 In immunocompromised patients, these fungi can be
angioinvasive, resulting in thrombosis and ischemia of the nasal
mucosa. This ultimately leads to tissue infarction and bone
destruction. We found a high rate of Aspergillus (41%), especially
among patients with hematological diseases (55%); among
patients with diabetes mellitus, 83% had a positive biopsy for
Mucoraceae. This is in contrast to the ﬁndings of Kasapoglu et al.10
who reported a predominance of Mucoraceae involvement. Ingley
et al.5 also observed a higher predisposition to Aspergillus among
patients with hematological malignancies and to Mucoraceae
among patients with diabetes mellitus. We did not observe a
higher morbidity–mortality rate in patients infected with Mucor-
aceae when compared to those with Aspergillus, which is in
accordance with the ﬁndings of Kasapoglu et al.,10 but in
disagreement with Ingley et al.5
Once AIFRS is suspected, a nasal endoscopy is essential to
evaluate the signs of fungal involvement. Pale mucosae, ulcers, and
granulation are present in up to 75% of patients examined by
endoscopy.2 Other signs such as tissue ischemia or tissue necrosis
can easily be seen in more severe cases of AIFRS. Biopsy of the
middle turbinate has been proposed as a means of diagnosis before
the disease is clearly established.4 This suggestion was based on
the observation that the middle turbinate is the most common
intranasal site of fungal invasion in patients with AIFRS.2,11,12 In
our study, we also observed that the middle meatus and the middle
turbinates were the most frequently involved sites (81% of cases).
The sensitivity of CT scans in the early stages of AIFRS is limited.
Bone erosion is a clear sign that the disease is established, but in
general this manifestation is only seen in the later stages.4,12 Other
suggestive signs of AIFRS found on CT scans are unilateral disease,
inﬁltration of the periantral fat planes, and severe mucosal edema.
In our study we observed a predominance of unilateral disease
with bone erosion, but orbital involvement was unusual (9% of
cases). Therefore, biopsy of the middle turbinate, nasal endoscopy,
and CT scans, taken together, are essential for an early diagnosis of
these patients and may allow a more favorable prognosis.
Once AIFRS is diagnosed, clinical and surgical treatment must
be initiated promptly. In our study, the antifungal drug most
commonly used was amphotericin B. Voriconazole has been
considered the treatment of choice for AIFRS related to Aspergil-
lus,1 and was introduced whenever Aspergillus was diagnosed
histopathologically.
Debridement of necrotic tissues is important in AIFRS patients
since the removal of devitalized tissue increases the ability of
antifungal drugs to reach infected areas, reducing the fungal
burden and slowing the progression of the disease. Also, this action
is not only local, since it reduces the stress on the development of
neutrophils, facilitating bone marrow recovery.12
In our study, the extent of the disease was inversely related to
the prognosis. Patients with AIFRS only in the lateral wall
presented a mortality rate of 33%; when AIFRS reached the nasalseptum, the mortality rate increased to 67%. All patients with AIFRS
beyond the nasal cavities died as a result of this disease. These
ﬁndings are in agreement with those of Lin et al.,13 who
demonstrated a mortality rate of 26.7% when invasive aspergillosis
was restricted to the nasal cavity and sinuses compared to 88%
when the infection was highly disseminated. Gleissner et al.14
reported a mortality rate of 40% in patients with AIFRS involving
Mucoraceae, and it reached 89% in patients with disseminated
disease. Thus, early diagnosis and treatment are key to a successful
outcome in these high-risk patients, as also stated by Kasapoglu
et al.10
Besides the extent of the disease, the underlying medical
condition is another important factor in the disease prognosis.2 In
the present study, the mortality rate in patients with aplastic
anemia and diabetes mellitus was high (near 100% when
considering both groups together), while those with AIDS/HIV
all had a good outcome. Patients with hematological malignancies
showed an intermediate prognosis; a third of these patients died
due to AIFRS.
The overall mortality rate in our study was 50%. This rate is in
accordance with the literature reviewed.8,9 deShazo et al.1 stated
that the best outcome reported is near 50% survival. To improve
this mortality rate, rapid diagnosis and treatment are essential.
Survival also depends on controlling the predisposing factors of the
immunosuppression, such as improving bone marrow function in
patients with hematological diseases or chemotherapy.9
In conclusion, this clinical series clearly shows that the
diagnosis of AIFRS is difﬁcult and requires multidisciplinary
assessment of the patient. Nasal endoscopy, biopsy of the middle
turbinate, and CT scans are essential to establish a rapid diagnosis
of AIFRS. The extent of AIFRS and the underlying medical disease
are the main factors related to the prognosis, but not the
classiﬁcation of the fungus isolated.
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